Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Chinese Patent Office
Mallinckrodt
AstraZeneca
Dow
QuintilesIMS
McKinsey
Moodys
Cerilliant

Generated: October 17, 2017

DrugPatentWatch Database Preview

Naratriptan hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for naratriptan hydrochloride and what is the scope of naratriptan hydrochloride freedom to operate?

Naratriptan hydrochloride
is the generic ingredient in two branded drugs marketed by Heritage Pharms Inc, Paddock Llc, Mylan Pharms Inc, Orchid Hlthcare, Teva Pharms, Sun Pharm Inds Ltd, Glaxosmithkline Llc, Apotex Corp, West-ward Pharms Int, and Sandoz, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for naratriptan hydrochloride. Seven suppliers are listed for this compound.

Summary for Generic Name: naratriptan hydrochloride

US Patents:0
Tradenames:2
Applicants:10
NDAs:10
Drug Master File Entries: see list6
Suppliers / Packagers: see list7
Bulk Api Vendors: see list48
Clinical Trials: see list2,289
Patent Applications: see list557
Therapeutic Class:Antimigraine Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:naratriptan hydrochloride at DailyMed

Pharmacology for Ingredient: naratriptan hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Llc
AMERGE
naratriptan hydrochloride
TABLET;ORAL020763-001Feb 10, 1998ABRXYesYes► Subscribe► Subscribe► Subscribe
Paddock Llc
NARATRIPTAN
naratriptan hydrochloride
TABLET;ORAL091326-001Jul 8, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
NARATRIPTAN
naratriptan hydrochloride
TABLET;ORAL090288-002Jul 7, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharms Inc
NARATRIPTAN
naratriptan hydrochloride
TABLET;ORAL200502-002Feb 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Orchid Hlthcare
NARATRIPTAN
naratriptan hydrochloride
TABLET;ORAL091441-001Apr 30, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
NARATRIPTAN
naratriptan hydrochloride
TABLET;ORAL202431-002May 31, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Orchid Hlthcare
NARATRIPTAN
naratriptan hydrochloride
TABLET;ORAL091441-002Apr 30, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Corp
NARATRIPTAN
naratriptan hydrochloride
TABLET;ORAL091373-001Apr 22, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharms Inc
NARATRIPTAN
naratriptan hydrochloride
TABLET;ORAL200502-001Feb 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
NARATRIPTAN
naratriptan hydrochloride
TABLET;ORAL078751-002Jul 7, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: naratriptan hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc
AMERGE
naratriptan hydrochloride
TABLET;ORAL020763-002Feb 10, 1998► Subscribe► Subscribe
Glaxosmithkline Llc
AMERGE
naratriptan hydrochloride
TABLET;ORAL020763-001Feb 10, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Johnson and Johnson
McKinsey
Dow
Julphar
Daiichi Sankyo
Harvard Business School
US Army
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot